How Abetalipoproteinemia Affects Lipoproteins. Because of a genetic mutation, people with abetalipoproteinemia don't produce the protein needed to make lipoproteins.

The Abetalipoproteinemia Management Market is anticipated to expand from its current estimated value of US$ 147 million in 2023 to US$ 341 million by 2033, at a CAGR of 8.78%.. The growing popularity ...

The Abetalipoproteinemia Management Market is anticipated to expand from its current estimated value of US$ 147 million in 2023 to US$ 341 million by 2033, at a CAGR of 8.78%.. The growing popularity ...